← Back to headlines
Baron Capital Exits Apogee Therapeutics Following AbbVie Buyout
Baron Capital has divested its holdings in Apogee Therapeutics (APGE) after the company was acquired by AbbVie.
5 Aug, 12:17 — 5 Aug, 12:17
Sources
Showing 1 of 1 sources
Related Stories
Shein Shares Plunge on Hong Kong Stock Exchange Debut Amid Growth Concerns
25m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
27m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
30m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
35m ago